Enfermedad hiperprogresista relacionada con la terapia inmune: mecanismos moleculares, biomarcadores y estrategias

Xiao-Ming Zhang1,2, Fei-Yu Zhao3, Lin-Feng Gao2

  • 1Department of Thoracic Oncology, Respiratory and Critical Care Medicine, The Eighth Medical Center of People's Liberation Army General Hospital, Beijing 100091, China.

PubMed
Resumen

No abstract available in PubMed .